This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

WebMD Highlights Top Health Stories Of 2012

NEW YORK, Dec. 5, 2012 /PRNewswire/ -- WebMD Health Corp. (NASDAQ: WBMD), the leading source of health information, today released its 2012 Year in Health, an annual listing of the most popular health topics of the year for consumers and physicians. Although health care reform topped the consumer 2012 list, the topics varied from healthy living, including health management, to deadly diseases. For physicians, Medicare was a leading topic, with new screening guidelines and new drug approvals making the 2012 list.

"Certain news stories clearly resonate with consumers and physicians and proliferate across all media channels. This year, a Supreme Court ruling and presidential election focused the spotlight on health care reform," said Michael Smith, MD, WebMD's Chief Medical Editor. "Both consumers and physicians turned to WebMD and Medscape to better understand how the changing health care system may affect them."

WebMD uniquely understands consumer and physician search and sharing behaviors across mobile and desktop. Mobile devices empower and enable consumers and physicians to make important health decisions anytime, anywhere through our multiscreen platform.

WebMD's Top 10 Stories of the Year :

1.   Health Care Reform Under Fire

2.  Deadly Diseases

3.  New Weight Loss Drugs

4.  Do Men Need a PSA Test?

5.  Fungal Meningitis Outbreak

6.  Are We Sitting Our Lives Away?

7.   Where's My Excedrin?

8.   The Dangers of Designer Drugs

9.   Children Developing (Adult) Chronic Conditions

10.   Food and Drink Villains

Medscape Top 10 Stories of the Year :

1.  Supreme Court Upholds Health Care Reform

2.  Are Physicians Coding Too Many 99214s?

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs